Elevance Health IncELV
▲ PositiveCapitalrelevance
Stock is undervalued per valuation analysis, trading at a discount to peers and sector average.
Impact on stocks 1
Health Care
Elevance Health IncElevance Health has returned 22.7% over the past year, yet valuation checks suggest the stock remains undervalued. It trades at about 17.3 times earnings, well below the healthcare sector average of roughly 25.9 times and a peer group average of about 43.1 times. A tailored fair price-to-earnings ratio for Elevance Health is estimated at around 33.3 times, implying a sizeable discount. The stock screens as undervalued in five of six valuation tests, though concerns about a shrinking customer base and Medicaid risk persist.
Elevance Health IncStock is undervalued per valuation analysis, trading at a discount to peers and sector average.